StockData
IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Iambic Therapeutics, Inc.

$16.34−7.47 (-31.37%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Iambic Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Iambic Therapeutics filed with the SEC